PCMT1 and breast cancer: Given that NUP43 is significantly associated with the prognosis of different subtypes of breast cancer, we analyzed the prognosis of PCMT1 in different subtypes of breast cancer, and the results showed that high expression of PCMT1 was significantly associated with poor prognosis in the luminal A subtype (see Supplementary Figure 3).